Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose amoxicillin dual therapy for Helicobacter pylori infection
ChiCTR2000031056Phase 4Not yet recruiting
- Sponsor
- Affiliated Hospital of Southwest Medical University
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of amoxicillin, esomeprazole and bismuth subsalicylate in Helicobacter pylori infection (2 arms), sponsored by Affiliated Hospital of Southwest Medical University. Primary endpoint: Helicobacter pylori eradication rate. Planned start Apr 2020; status: not yet recruiting.
02
Drugs
amoxicillinesomeprazolebismuth subsalicylate
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2000031056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000031056.